Bal Pharma has informed that pursuant to the Code of conduct of the Company and as per the amended provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing with the securities of the Company on the designated employees and their relatives was closed from 1st January 2020 and up to 48 hours of the declaration of the financial results of the Company, for the quarter ended 31/12/2019. The date of the Board meeting for declaration of the financial results for December 2019 quarter will be intimated to the exchange in due course. As the above said provisions for closure of trading window from the first day of every quarter was incorporated in its internal Code of Conduct, in compliance with the amended SEBI (PIT) Regulations and communicated to designated persons as standing code of conduct, the management has decided to omit communicating the trading window closure intimation on quarterly basis to the exchanges and employees.
The above information is a part of company’s filings submitted to BSE.
